Citigroup Inc Eli Lilly & CO Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Citigroup Inc holds 752,426 shares of LLY stock, worth $586 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

752,426

Previous 774,634 2.87%

Holding current value

$586 Million

Previous $701 Million 4.95%

% of portfolio

0.39%

Previous 0.46%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $17.1 Million - $21.3 Million	-22,208 Reduced 2.87%	752,426 $667 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $115 Million - $144 Million	158,051 Added 25.63%	774,634 $701 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $19.8 Million - $26.5 Million	33,482 Added 5.74%	616,583 $480 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $40.3 Million - $47.6 Million	-76,807 Reduced 11.64%	583,101 $340 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $13.6 Million - $18.7 Million	-31,213 Reduced 4.52%	659,908 $354 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $22.5 Million - $30.1 Million	-64,176 Reduced 8.5%	691,121 $324 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $24.4 Million - $28.6 Million	-78,531 Reduced 9.42%	755,297 $259 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $55.4 Million - $64.5 Million	-172,203 Reduced 17.12%	833,828 $305 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $81.4 Million - $92.7 Million	274,428 Added 37.51%	1,006,031 $325 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $16.4 Million - $19.2 Million	-58,818 Reduced 7.44%	731,603 $237 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $6.5 Million - $8.08 Million	27,710 Added 3.63%	790,421 $226 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $9.66 Million - $12 Million	-42,941 Reduced 5.33%	762,711 $211 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $179 Million - $220 Million	805,652 New	805,652 $186 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account